Ketamine or Placebo in Patients With Major Depression and Advanced Cancer
Status:
Recruiting
Trial end date:
2022-12-19
Target enrollment:
Participant gender:
Summary
Major depression (MD) is a psychiatric disorder characterized by a persistent feeling of
sadness, anhedonia or a decreased perception of pleasurable experiences, as well as appetite
alterations and weight variations, sleep disorders, altered psychomotor skills, fatigue,
guilt, decreased self-worth, suicidal thoughts and difficulty concentrating in a task (1).
MD is a frequent complication in patients who are diagnosed with advanced cancer.